Early treatment with GLP-1 after severe trauma preserves renal function in obese Zucker rats.

American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
Lusha XiangRobert L Hester

Abstract

Early posttrauma hyperglycemia (EPTH) is correlated with later adverse outcomes, including acute kidney injury (AKI). Controlling EPTH in the prehospital setting is difficult because of the variability in the ideal insulin dosage and the potential risk of hypoglycemia, especially in those with confounding medical comorbidities of obesity and insulin resistance. Glucagon-like peptide-1 (GLP-1) controls glucose levels in a glucose-dependent manner and is a current target in antidiabetic therapy. We have shown that after orthopedic trauma, obese Zucker rats exhibit EPTH and a later development of AKI (within 24 h). We hypothesized that GLP-1 treatment after trauma decreases EPTH and protects renal function in obese Zucker rats. Obese Zucker rats (~12 wk old) were fasted for 4 h before trauma. Soft tissue injury, fibula fracture, and homogenized bone component injection were then performed in both hind limbs to induce severe extremity trauma. Plasma glucose levels were measured before and 15, 30, 60, 120, 180, 240, and 300 min after trauma. GLP-1 (3 μg·kg-1·h-1, 1.5 ml/kg total) or saline was continuously infused from 30 min to 5 h after trauma. Afterwards, rats were placed in metabolic cages overnight for urine collection. The fol...Continue Reading

References

Jun 1, 1988·The Journal of Surgical Research·J A GalatR S Rhodes
Jul 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hugh M PatersonJames A Lederer
Jun 5, 2004·The Journal of Trauma·Amanda M LairdMichael C Chang
Dec 31, 2005·The Journal of Trauma·Carlos V R BrownDemetrios Demetriades
Apr 14, 2006·The Journal of Trauma·Mathijs VogelzangMaarten W N Nijsten
Sep 27, 2006·Journal of the American College of Surgeons·David J CieslaAngela Sauaia
Dec 13, 2007·The Journal of Trauma·Jason L SperryJospeh P Minei
Jul 22, 2008·Diabetes & Metabolism·J-F GautierJ Girard
Feb 11, 2010·Journal of Diabetes Science and Technology·James Eakins
Nov 4, 2010·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Lusha XiangGeorge V Russell
Sep 17, 2011·Contributions to Nephrology·Prabhleen Singh, Mark D Okusa
Oct 18, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Lusha XiangRobert Hester
Jan 31, 2013·Clinical and Experimental Pharmacology & Physiology·Prabhleen SinghLina Nordquist
Mar 7, 2013·The Journal of Clinical Endocrinology and Metabolism·Jeppe SkovJens Sandahl Christiansen
Mar 22, 2013·Critical Care : the Official Journal of the Critical Care Forum·Sven-Erik RickstenBengt Redfors
Nov 23, 2013·Annals of Surgery·Laurent G GlanceAndrew W Dick
Dec 5, 2013·Physiological Reports·Peter N MittwedeRobert L Hester
Jan 15, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Lusha XiangRobert L Hester
Apr 22, 2010·Journal of Diabetes Investigation·Yutaka SeinoDaisuke Yabe
Jun 6, 2014·International Journal of Endocrinology·Fangming XiuMarc G Jeschke
Jun 16, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Lusha XiangRobert L Hester
Nov 28, 2014·American Journal of Physiology. Renal Physiology·Peter N MittwedeRobert L Hester
Jul 16, 2015·The Review of Diabetic Studies : RDS·Theodosios D FilippatosMoses S Elisaf
Oct 9, 2015·American Journal of Physiology. Renal Physiology·Lívia X S FarahAdriana C C Girardi
Feb 22, 2016·The American Journal of the Medical Sciences·Nagham JafarKenneth Nugent
Nov 21, 2016·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·A B PedersenC F Christiansen
Dec 21, 2016·Critical Care : the Official Journal of the Critical Care Forum·Lara ZafraniCan Ince
Jul 10, 2017·European Journal of Pharmacology·Daniella B R Insuela, Vinicius F Carvalho
Oct 17, 2017·Current Opinion in Critical Care·Anatole HarroisJacques Duranteau
Mar 7, 2018·Nature Immunology·Markus Huber-LangPeter A Ward
Aug 24, 2018·Nature Reviews. Nephrology·Eric A J HosteLakhmir S Chawla

❮ Previous
Next ❯

Methods Mentioned

BETA
prophylactic therapy
urine volume
ELISA

Software Mentioned

PowerLab
SPSS

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.